Literature DB >> 24414066

Endothelin-1-induced vasoconstriction does not require intracellular Ca²⁺ waves in arteries from rats exposed to intermittent hypoxia.

Jessica M Osmond1, Laura V Gonzalez Bosc, Benjimen R Walker, Nancy L Kanagy.   

Abstract

Sleep apnea is associated with cardiovascular disease, and patients with sleep apnea have elevated plasma endothelin (ET)-1 concentrations. Rats exposed to intermittent hypoxia (IH), a model of sleep apnea, also have increased plasma ET-1 concentrations and heightened constriction to ET-1 in mesenteric arteries without an increase in global vascular smooth muscle cell Ca(2+) concentration ([Ca(2+)]). Because ET-1 has been shown to increase the occurrence of propagating Ca(2+) waves, we hypothesized that ET-1 increases Ca(2+) wave activity in mesenteric arteries, rather than global [Ca(2+)], to mediate enhanced vasoconstriction after IH exposure. Male Sprague-Dawley rats were exposed to sham or IH conditions for 7 h/day for 2 wk. Mesenteric arteries from sham- and IH-exposed rats were isolated, cannulated, and pressurized to 75 mmHg to measure ET-1-induced constriction as well as changes in global [Ca(2+)] and Ca(2+) wave activity. A low concentration of ET-1 (1 nM) elicited similar vasoconstriction and global Ca(2+) responses in the two groups. Conversely, ET-1 had no effect on Ca(2+) wave activity in arteries from sham rats but significantly increased wave frequency in arteries from IH-exposed rats. The ET-1-induced increase in Ca(2+) wave frequency in arteries from IH rats was dependent on phospholipase C and inositol 1,4,5-trisphosphate receptor activation, yet inhibition of phospholipase C and the inositol 1,4,5-trisphosphate receptor did not prevent ET-1-mediated vasoconstriction. These results suggest that although ET-1 elevates Ca(2+) wave activity after IH exposure, increases in wave activity are not associated with increased vasoconstriction.

Entities:  

Keywords:  Ca2+ oscillations; endothelin-1; intermittent hypoxia

Mesh:

Substances:

Year:  2014        PMID: 24414066      PMCID: PMC3949067          DOI: 10.1152/ajpheart.00643.2013

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  38 in total

1.  Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension.

Authors:  Kyan J Allahdadi; Benjimen R Walker; Nancy L Kanagy
Journal:  Hypertension       Date:  2005-02-28       Impact factor: 10.190

2.  Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect.

Authors:  Shang-Zhong Xu; Fanning Zeng; Guylain Boulay; Christian Grimm; Christian Harteneck; David J Beech
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation.

Authors:  Sergio de Frutos; Rhyannon Spangler; Dominique Alò; Laura V González Bosc
Journal:  J Biol Chem       Date:  2007-04-02       Impact factor: 5.157

4.  Norepinephrine-induced Ca(2+) waves depend on InsP(3) and ryanodine receptor activation in vascular myocytes.

Authors:  F X Boittin; N Macrez; G Halet; J Mironneau
Journal:  Am J Physiol       Date:  1999-07

5.  Effects of obstructive sleep apnea on endothelin-1 and blood pressure.

Authors:  B G Phillips; K Narkiewicz; C A Pesek; W G Haynes; M E Dyken; V K Somers
Journal:  J Hypertens       Date:  1999-01       Impact factor: 4.844

6.  Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an alpha-actin intronic enhancer.

Authors:  Laura V Gonzalez Bosc; Jeff J Layne; Mark T Nelson; David C Hill-Eubanks
Journal:  J Biol Chem       Date:  2005-04-27       Impact factor: 5.157

7.  Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB).

Authors:  K Togashi; H Inada; M Tominaga
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

8.  NFATc3 is required for intermittent hypoxia-induced hypertension.

Authors:  Sergio de Frutos; Laura Duling; Dominique Alò; Tammy Berry; Olan Jackson-Weaver; Mary Walker; Nancy Kanagy; Laura González Bosc
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

9.  ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats.

Authors:  Kyan J Allahdadi; Benjimen R Walker; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-24       Impact factor: 4.733

10.  Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia.

Authors:  Kyan J Allahdadi; Tom W Cherng; Hemanth Pai; Ana Q Silva; Benjimen R Walker; Leif D Nelin; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-30       Impact factor: 4.733

View more
  2 in total

1.  Anti-hypotensive treatment and endothelin blockade synergistically antagonize exercise fatigue in rats under simulated high altitude.

Authors:  Daniel Radiloff; Yulin Zhao; Alina Boico; Gert Blueschke; Gregory Palmer; Andrew Fontanella; Mark Dewhirst; Claude A Piantadosi; Robert Noveck; David Irwin; Karyn Hamilton; Bruce Klitzman; Thies Schroeder
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

2.  Expression of MYPT1, CPI-17 and MLC20 in ileum of neonatal mouse NEC model and its significance.

Authors:  Yinyu Yin; Yiping Li; Jian Pan; Ruze Tang; Jie Zhu; Zhenfang Qin; Xiaobing Xu; Jian Wang
Journal:  Exp Ther Med       Date:  2017-07-12       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.